In vitro evaluation of potential drug interactions mediated by cytochrome P450 and transporters for luseogliflozin, an SGLT2 inhibitor.

about

In vitro evaluation of potential drug interactions mediated by cytochrome P450 and transporters for luseogliflozin, an SGLT2 inhibitor.

Item

http://www.wikidata.org/entity/Q51692185

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

In vitro evaluation of potenti ...... gliflozin, an SGLT2 inhibitor.

@en

In vitro evaluation of potenti ...... gliflozin, an SGLT2 inhibitor.

@nl

type

Item

label

In vitro evaluation of potenti ...... gliflozin, an SGLT2 inhibitor.

@en

In vitro evaluation of potenti ...... gliflozin, an SGLT2 inhibitor.

@nl

prefLabel

In vitro evaluation of potenti ...... gliflozin, an SGLT2 inhibitor.

@en

In vitro evaluation of potenti ...... gliflozin, an SGLT2 inhibitor.

@nl

P1476

In vitro evaluation of potenti ...... gliflozin, an SGLT2 inhibitor.

@en

P2093

Atsunori Miyata

http://www.w3.org/2001/XMLSchema#string

Hiromi Endo

http://www.w3.org/2001/XMLSchema#string

Jun-Ichi Yamaguchi

http://www.w3.org/2001/XMLSchema#string

Kagumi Bando

http://www.w3.org/2001/XMLSchema#string

Masatoshi Hasegawa

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Nakai

http://www.w3.org/2001/XMLSchema#string

Yoko Mano

http://www.w3.org/2001/XMLSchema#string

Yoshiki Fukasawa

http://www.w3.org/2001/XMLSchema#string

Yukihiro Chino

http://www.w3.org/2001/XMLSchema#string

P2860

Membrane transporters in drug development

Predicting in vivo drug interactions from in vitro drug discovery data.

Drug interaction studies: study design, data analysis, and implications for dosing and labeling.

Drug-drug interactions with sodium-glucose cotransporters type 2 (SGLT2) inhibitors, new oral glucose-lowering agents for the management of type 2 diabetes mellitus.

Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice.

Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals.

Absence of Drug-Drug Interactions Between Luseogliflozin, a Sodium-Glucose Co-transporter-2 Inhibitor, and Various Oral Antidiabetic Drugs in Healthy Japanese Males.

The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins.

Evaluation of 6β-hydroxycortisol, 6β-hydroxycortisone, and a combination of the two as endogenous probes for inhibition of CYP3A4 in vivo.

Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance.

P304

314-323

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00498254.2016.1193913

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27324291

http://www.w3.org/2001/XMLSchema#string